[HTML][HTML] No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors
PJ Woestenberg, AJ King, MAB van der Sande… - Journal of Infection, 2017 - Elsevier
Objectives Data from a vaccine trial and from post-vaccine surveillance in the United
Kingdom have suggested that the bivalent HPV-16/18 vaccine offers cross-protection …
Kingdom have suggested that the bivalent HPV-16/18 vaccine offers cross-protection …
The clinical and economic benefits of school‐based quadrivalent HPV vaccination in Singapore
Objective To investigate the clinical and economic impacts of school‐based administration
of the quadrivalent HPV vaccine. Methods A retrospective health‐economic analysis was …
of the quadrivalent HPV vaccine. Methods A retrospective health‐economic analysis was …
[PDF][PDF] HPV vaccines: promise and challenges
A Kols, J Sherris - Seattle (WA): PATH, 2000 - screening.iarc.fr
Page 2 already infected with HPV. Therefore, medical researchers also are investigating
therapeutic vaccines for use as an adjunct to standard therapies. Such a vaccine could (1) …
therapeutic vaccines for use as an adjunct to standard therapies. Such a vaccine could (1) …
Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism
M Frisch, A Besson, KKB Clemmensen… - International Journal …, 2018 - academic.oup.com
Background In recent years, human papillomavirus (HPV) vaccination of boys has been
added to childhood vaccination programmes in several countries but, so far, no systematic …
added to childhood vaccination programmes in several countries but, so far, no systematic …
[HTML][HTML] A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years …
T Batmunkh, MT Dalmau, ME Munkhsaikhan… - Vaccine, 2020 - Elsevier
Background Emerging observational evidence suggests a single-dose of human
papillomavirus (HPV) vaccine may be protective against vaccine-targeted HPV infection and …
papillomavirus (HPV) vaccine may be protective against vaccine-targeted HPV infection and …
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 …
W Chen, Y Zhao, X Xie, J Liu, J Li, C Zhao, S Wang… - Vaccine, 2019 - Elsevier
Background A quadrivalent human papillomavirus (qHPV) vaccine (HPV6/11/16/18) has
demonstrated efficacy and acceptable safety in international studies. However, these studies …
demonstrated efficacy and acceptable safety in international studies. However, these studies …
[HTML][HTML] Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential …
S Hartwig, JJ Baldauf, G Dominiak-Felden… - Papillomavirus …, 2015 - Elsevier
Introduction A second generation HPV vaccine has been developed for the prevention of
anogenital cancers and precancerous lesions of the cervix, vulva, vagina, anus and of …
anogenital cancers and precancerous lesions of the cervix, vulva, vagina, anus and of …
Substantial decline in prevalence of vaccine-type and nonvaccine-type human papillomavirus (HPV) in vaccinated and unvaccinated girls 5 years after implementing …
B Feiring, I Laake, IK Christiansen… - The Journal of …, 2018 - academic.oup.com
Background In 2009, quadrivalent human papillomavirus (HPV) vaccine was introduced in a
school-based single-cohort program targeting 12-year-old girls in Norway. We estimated the …
school-based single-cohort program targeting 12-year-old girls in Norway. We estimated the …
The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010–2016
D Mesher, K Panwar, SL Thomas… - The Journal of …, 2018 - academic.oup.com
Background The national human papillomavirus (HPV) immunization program was
introduced in England in September 2008 using the bivalent vaccine. Methods We collected …
introduced in England in September 2008 using the bivalent vaccine. Methods We collected …
Human papillomavirus vaccination in males
AR Giuliano - Gynecologic oncology, 2007 - Elsevier
Human papillomavirus (HPV) is one of the most common sexually transmitted diseases
(STDs) and is frequently presented clinically as anogenital warts in both males and females …
(STDs) and is frequently presented clinically as anogenital warts in both males and females …